CapEx at other companies
Other financials
Where this comes from
Reported directly by Cogent Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.
The official record: Cogent Biosciences, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Cogent Biosciences, Inc.'s capex.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Cogent Biosciences, Inc.'s capex?
- Cogent Biosciences, Inc. (COGT) reported capex of $449K in Q1 2026.
- How has Cogent Biosciences, Inc.'s capex changed year-over-year?
- Cogent Biosciences, Inc.'s capex decreased by 17.9% year-over-year, from $547K to $449K.
- What is the long-term trend for Cogent Biosciences, Inc.'s capex?
- Over 3 years (2022 to 2025), Cogent Biosciences, Inc.'s capex has grown at a -39.0% compound annual growth rate (CAGR), from $6.86M to $1.55M.
- What does capex mean?
- Cash spent on property, plant, and equipment — the primary measure of investment in productive capacity and infrastructure.